An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...
A Richmond husband and father with a lifelong love for biking is giving back to his daughter and other patients facing type 1 ...
The UK Government must ‘speed up access’ of new treatments for type 1 diabetes, says Nick Smith MP, as he joined campaigners in Westminster.
A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every ...
A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS.
It has been dubbed the biggest diabetes breakthrough for a century.
The United States now spends more than $5 trillion annually on healthcare, while it is projected that $1 trillion in annual ...
SAB Biotherapeutics Inc. (NASDAQ:SABS) is one of the 10 best stocks under $10 that could triple. On July 7, SAB ...
Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’ ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...
The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results